𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance

✍ Scribed by Paul Kirk; John Paul Carpenter; Mark A Tanner; Dudley J Pennell


Publisher
BioMed Central
Year
2011
Tongue
English
Weight
893 KB
Volume
13
Category
Article
ISSN
1097-6647

No coin nor oath required. For personal study only.

✦ Synopsis


Background

Heart failure remains a major cause of mortality in thalassaemia major. The possible role of cardiac fibrosis in thalassemia major in the genesis of heart failure is not clear. It is also unclear whether cardiac fibrosis might arise as a result of heart failure.

Methods

We studied 45 patients with thalassaemia major who had a wide range of current cardiac iron loading and included patients with prior and current heart failure. Myocardial iron was measured using T2* cardiovascular magnetic resonance (CMR), and following this, late gadolinium enhancement (LGE) was used to determine the presence of macroscopic myocardial fibrosis.

Results

The median myocardial T2* in all patients was 22.6 ms (range 5.3-58.8 ms). Fibrosis was detected in only one patient, whose myocardial T2* was 20.1 ms and left ventricular ejection fraction 57%. No fibrosis was identified in 5 patients with a history of heart failure with full recovery, in 3 patients with current left ventricular dysfunction undergoing treatment, or in 18 patients with myocardial iron loading with cardiacT2* < 20 ms at the time of scan.

Conclusion

This study shows that macroscopic myocardial fibrosis is uncommon in thalassemia major across a broad spectrum of myocardial iron loading. Importantly, there was no macroscopic fibrosis in patients with current or prior heart failure, or in patients with myocardial iron loading without heart failure. Therefore if myocardial fibrosis indeed contributes to myocardial dysfunction in thalassemia, our data combined with the knowledge that the myocardial dysfunction of iron overload can be reversed, indicates that any such fibrosis would need to be both microscopic and reversible.


πŸ“œ SIMILAR VOLUMES


Myocardial fibrosis by delayed enhanceme
✍ Alessia Pepe; Antonella Meloni; Zelia Borsellino; Maria Chiara Dell'Amico; Vince πŸ“‚ Article πŸ“… 2010 πŸ› BioMed Central 🌐 English βš– 102 KB

Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical researc h in our lifetime.

Extent of late gadolinium enhancement de
✍ Stephan Fluechter; JΓΌrgen Kuschyk; Christian Wolpert; Christina Doesch; Christia πŸ“‚ Article πŸ“… 2010 πŸ› BioMed Central 🌐 English βš– 656 KB

Background: Myocardial fibrosis is frequently identified in patients with hypertrophic cardiomyopathy (HCM). The aim of this study was to investigate the role of myocardial fibrosis detected by late gadolinium-enhancement (LGE) cardiovascular magnetic resonance (CMR) as a potential arrhythmogenic su